<DOC>
	<DOC>NCT01024478</DOC>
	<brief_summary>The multicenter study evaluates the diagnostic performance of 3.0 T contrast-enhanced whole-heart coronary MRA in patients with suspected coronary artery disease.</brief_summary>
	<brief_title>Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial</brief_title>
	<detailed_description>This is a multicenter trial evaluated the diagnostic ability of 3.0 T contrast-enhanced whole-heart coronary MRA to detect significant coronary artery stenosis among patients with suspected CAD. A total of 272 patients will be prospectively enrolled from 8 cities in China.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Suspected CAD, scheduled for DSA Sinus rhythm Contraindications to MR examination: pacemaker, intraauricular implants, intracranial clips, thoracotomy, claustrophobia, orthopnea Acute coronary syndrome Atria fibrillation Coronary stents Bypass grafts Renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance &lt;60 ml/min/1.73 m2)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Coronary Artery</keyword>
	<keyword>Magnetic Resonance Angiography</keyword>
	<keyword>Coronary Artery disease</keyword>
	<keyword>Multicenter Trial</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>